Ursodeoxycholic acid therapy in primary biliary cirrhosis

M. Podda, A. Crosignani, P. M. Battezzati, M. Quagliuolo, C. Valsania, P. Invernizzi, M. Zuin

Research output: Contribution to journalArticle

Abstract

A review is made of the literature regarding the present status of ursodeoxycholic acid in the treatment of primary biliary cirrhosis, focusing on the difficulties encountered in establishing the efficacy of this and any other therapy in the management of the disease. It is concluded that further studies or, at least, an updated meta-analysis including the final data emerging from the multicentre, long-term, randomised, double-blind, controlled trials currently under way are needed to establish the clinical importance of ursodeoxycholic acid as a therapeutic agent in primary biliary cirrhosis.

Original languageEnglish
Pages (from-to)114-117
Number of pages4
JournalItalian Journal of Gastroenterology
Volume28
Issue number2
Publication statusPublished - 1996

Fingerprint

Ursodeoxycholic Acid
Biliary Liver Cirrhosis
Disease Management
Meta-Analysis
Therapeutics

Keywords

  • Cholestasis
  • Primary biliary cirrhosis
  • Ursodeoxycholic acid

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Podda, M., Crosignani, A., Battezzati, P. M., Quagliuolo, M., Valsania, C., Invernizzi, P., & Zuin, M. (1996). Ursodeoxycholic acid therapy in primary biliary cirrhosis. Italian Journal of Gastroenterology, 28(2), 114-117.

Ursodeoxycholic acid therapy in primary biliary cirrhosis. / Podda, M.; Crosignani, A.; Battezzati, P. M.; Quagliuolo, M.; Valsania, C.; Invernizzi, P.; Zuin, M.

In: Italian Journal of Gastroenterology, Vol. 28, No. 2, 1996, p. 114-117.

Research output: Contribution to journalArticle

Podda, M, Crosignani, A, Battezzati, PM, Quagliuolo, M, Valsania, C, Invernizzi, P & Zuin, M 1996, 'Ursodeoxycholic acid therapy in primary biliary cirrhosis', Italian Journal of Gastroenterology, vol. 28, no. 2, pp. 114-117.
Podda M, Crosignani A, Battezzati PM, Quagliuolo M, Valsania C, Invernizzi P et al. Ursodeoxycholic acid therapy in primary biliary cirrhosis. Italian Journal of Gastroenterology. 1996;28(2):114-117.
Podda, M. ; Crosignani, A. ; Battezzati, P. M. ; Quagliuolo, M. ; Valsania, C. ; Invernizzi, P. ; Zuin, M. / Ursodeoxycholic acid therapy in primary biliary cirrhosis. In: Italian Journal of Gastroenterology. 1996 ; Vol. 28, No. 2. pp. 114-117.
@article{4729fe732ba3421fb4c89fc9a56e9f06,
title = "Ursodeoxycholic acid therapy in primary biliary cirrhosis",
abstract = "A review is made of the literature regarding the present status of ursodeoxycholic acid in the treatment of primary biliary cirrhosis, focusing on the difficulties encountered in establishing the efficacy of this and any other therapy in the management of the disease. It is concluded that further studies or, at least, an updated meta-analysis including the final data emerging from the multicentre, long-term, randomised, double-blind, controlled trials currently under way are needed to establish the clinical importance of ursodeoxycholic acid as a therapeutic agent in primary biliary cirrhosis.",
keywords = "Cholestasis, Primary biliary cirrhosis, Ursodeoxycholic acid",
author = "M. Podda and A. Crosignani and Battezzati, {P. M.} and M. Quagliuolo and C. Valsania and P. Invernizzi and M. Zuin",
year = "1996",
language = "English",
volume = "28",
pages = "114--117",
journal = "Italian Journal of Gastroenterology",
issn = "0392-0623",
publisher = "Piccin Editore",
number = "2",

}

TY - JOUR

T1 - Ursodeoxycholic acid therapy in primary biliary cirrhosis

AU - Podda, M.

AU - Crosignani, A.

AU - Battezzati, P. M.

AU - Quagliuolo, M.

AU - Valsania, C.

AU - Invernizzi, P.

AU - Zuin, M.

PY - 1996

Y1 - 1996

N2 - A review is made of the literature regarding the present status of ursodeoxycholic acid in the treatment of primary biliary cirrhosis, focusing on the difficulties encountered in establishing the efficacy of this and any other therapy in the management of the disease. It is concluded that further studies or, at least, an updated meta-analysis including the final data emerging from the multicentre, long-term, randomised, double-blind, controlled trials currently under way are needed to establish the clinical importance of ursodeoxycholic acid as a therapeutic agent in primary biliary cirrhosis.

AB - A review is made of the literature regarding the present status of ursodeoxycholic acid in the treatment of primary biliary cirrhosis, focusing on the difficulties encountered in establishing the efficacy of this and any other therapy in the management of the disease. It is concluded that further studies or, at least, an updated meta-analysis including the final data emerging from the multicentre, long-term, randomised, double-blind, controlled trials currently under way are needed to establish the clinical importance of ursodeoxycholic acid as a therapeutic agent in primary biliary cirrhosis.

KW - Cholestasis

KW - Primary biliary cirrhosis

KW - Ursodeoxycholic acid

UR - http://www.scopus.com/inward/record.url?scp=0029896637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029896637&partnerID=8YFLogxK

M3 - Article

C2 - 8782007

AN - SCOPUS:0029896637

VL - 28

SP - 114

EP - 117

JO - Italian Journal of Gastroenterology

JF - Italian Journal of Gastroenterology

SN - 0392-0623

IS - 2

ER -